Richard Brudnick
Director/Board Member chez INFLARX N.V.
Fortune : 90 129 $ au 31/03/2024
Profil
Richard H.
Brudnick is currently serving as an Independent Non-Executive Director at InflaRx NV since 2019, an Independent Director at Scholar Rock Holding Corp.
since 2023, an Independent Director at Volition America, Inc. since 2021, a Director at Tamarix Pharma Ltd since 2021, a Venture Advisor at Israel Biotech Fund since 2018, and the Chief Business Officer at Prime Medicine, Inc. since 2022.
Previously, Mr. Brudnick held the position of President & Chief Executive Officer at James Brudnick Co., Inc. from 1984 to 1998.
He also served as an Independent Director at VolitionRX Ltd.
from 2021 to 2023, Senior VP-Corporate Development & Strategy at Biogen, Inc. from 2014 to 2016, Chief Business Officer & Head-Strategy at Codiak BioSciences, Inc. from 2018 to 2022, and Executive Vice President-Business Development at Bioverativ, Inc. from 2016 to 2018.
Mr. Brudnick obtained his undergraduate degree from Massachusetts Institute of Technology in 1978.
He also holds an MBA from MIT Sloan School of Management, which he earned in 1980.
Additionally, he has completed undergraduate and graduate studies at MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INFLARX N.V.
0,08% | 31/12/2023 | 50 000 ( 0,08% ) | 77 000 $ | 31/03/2024 |
VOLITIONRX LIMITED
0,02% | 24/04/2023 | 17 343 ( 0,02% ) | 13 129 $ | 31/03/2024 |
| 06/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
PRIME MEDICINE, INC.
-.--% | 21/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Richard Brudnick
| Sociétés | Poste | Début |
|---|---|---|
| INFLARX N.V. | Director/Board Member | 14/02/2019 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 01/07/2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 06/04/2023 |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Director/Board Member | 25/03/2021 |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Director/Board Member | 01/10/2021 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | 01/01/2018 |
Anciens postes connus de Richard Brudnick
| Sociétés | Poste | Fin |
|---|---|---|
| VOLITIONRX LIMITED | Director/Board Member | 23/06/2023 |
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/07/2022 |
| BIOVERATIV INC | Corporate Officer/Principal | 01/03/2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard Brudnick
| Massachusetts Institute of Technology | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| VOLITIONRX LIMITED | Health Technology |
| INFLARX N.V. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| James Brudnick Co., Inc. | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Health Services |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Health Technology |
